Patient Dosing Commenced in Reposa Phase 2/3 Clinical Trial Protocol to Assess Ihl-42X Drug in Patients With Obstructive Sleep Apnea
Reposa 2/3 期臨床試驗方案開始患者給藥,以評估阻塞性睡眠呼吸暫停患者的Ihl-42X藥物
Patient Dosing Commenced in Reposa Phase 2/3 Clinical Trial Protocol to Assess Ihl-42X Drug in Patients With Obstructive Sleep Apnea
Reposa 2/3 期臨床試驗方案開始患者給藥,以評估阻塞性睡眠呼吸暫停患者的Ihl-42X藥物
譯文內容由第三人軟體翻譯。